Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1. RT-PCR positive for nCOVID-19 within last 72 hours <br/ >2. Male and female patients with age above 18 years and below 65 years of age. <br/ >3. Patient willing to provide informed consent to participate into the trial. <br/ >4. Patient able to comply requirement of study and protocol. <br/ >5. Patient having SpO2 > 94 %, Respiratory rate < 24/min and temperature < 104 °F

1. RT-PCR positive for nCOVID-19 within last 72 hours <br/ >2. Male and female patients with age above 18 years and below 65 years of age. <br/ >3. Patient willing to provide informed consent to participate into the trial. <br/ >4. Patient able to comply requirement of study and protocol. <br/ >5. Patient having SpO2 > 94 %, Respiratory rate < 24/min and temperature < 104 °F

Nov. 13, 2021, 5:33 p.m. oms

Sept. 8, 2021, 1:30 a.m. oms

1. RT-PCR positive for nCOVID-19 within last 72 hours <br/ >2. Male and female patients with age above 18 years and below 65 years of age. <br/ >3. Patient willing to provide informed consent to participate into the trial. <br/ >4. Patient able to comply requirement of study and protocol. <br/ >5. Patient having SpO2 > 94 %, Respiratory rate < 24/min and temperature < 104 °F

1. RT-PCR positive for nCOVID-19 within last 72 hours <br/ >2. Male and female patients with age above 18 years and below 65 years of age. <br/ >3. Patient willing to provide informed consent to participate into the trial. <br/ >4. Patient able to comply requirement of study and protocol. <br/ >5. Patient having SpO2 > 94 %, Respiratory rate < 24/min and temperature < 104 °F